Cetera Investment Advisers’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56M Sell
10,262
-2,240
-18% -$373K ﹤0.01% 2616
2026
Q1
$2.62M Sell
12,502
-1,856
-13% -$466K ﹤0.01% 2034
2025
Q4
$4.08M Sell
14,358
-259
-2% -$81K ﹤0.01% 1604
2025
Q3
$4.51M Buy
14,617
+2,940
+25% +$921K 0.01% 1476
2025
Q2
$3.67M Buy
11,677
+5,222
+81% +$1.51M 0.01% 1398
2025
Q1
$1.7M Buy
6,455
+4,037
+167% +$1.09M ﹤0.01% 1868
2024
Q4
$631K Sell
2,418
-396
-14% -$99.7K ﹤0.01% 2503
2024
Q3
$655K Buy
2,814
+87
+3% +$17.9K ﹤0.01% 2435
2024
Q2
$550K Buy
2,727
+127
+5% +$22.9K ﹤0.01% 2515
2024
Q1
$446K Buy
2,600
+727
+39% +$136K ﹤0.01% 2689
2023
Q4
$406K Buy
+1,873
New +$321K ﹤0.01% 1604
2023
Q3
– Sell
-694
Closed -$200K – 2277
2023
Q2
$200K Sell
694
-50
-7% -$15.2K ﹤0.01% 1990
2023
Q1
$237K Sell
744
-20
-3% -$5.93K ﹤0.01% 1843
2022
Q4
$225K Buy
+764
New +$211K ﹤0.01% 1842

Other funds holding PODD

Cetera Investment Advisers's PODD Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Insulet (PODD) stake by 18% in Q2 2026, selling an estimated $373K and leaving 10,262 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2616.

Cetera Investment Advisers first reported a position in PODD in Q4 2022 and has held it in 14 quarters since. The position peaked at $4.51M in Q3 2025. 731 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Cetera Investment Advisers held 10,262 shares of Insulet worth $1.56M as of Q2 2026.
  • Cetera Investment Advisers sold 2,240 Insulet shares in Q2 2026, an estimated $373K.
  • Insulet made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2616 holding.
  • Cetera Investment Advisers first reported a position in Insulet in Q4 2022 and has held it in 14 quarters since.
  • Cetera Investment Advisers's Insulet position peaked at $4.51M in Q3 2025.
  • 731 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.